Top Markets
Coin of the day
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA
Classificação em ações #32451
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on... Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
Preço da ação
$1.11
Última sincronização: 2026-08-17
Valor de mercado
$10.06M
Variação (1 dia)
1.38%
Variação (1 ano)
-55.98%
País
US
Negociar Lisata Therapeutics, Inc. (LSTA)

Categoria

Histórico de preços das ações de Lisata Therapeutics, Inc. (LSTA)
Preço de fecho mais alto: $1.12 em 2026-08-01

Preço de fecho mais baixo: $188.93K em 1999-03-01
Histórico de preços das ações da Lisata Therapeutics, Inc. de 1999 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 52.31%
2025 -28.03%
2024 3.05%
2023 -6.25%
2022 -78.23%
2021 -42.33%
2020 -36.52%
2019 -44.38%
2018 26.19%
2017 2.72%
2016 -70.04%
2015 -68.59%
2014 -44.74%
2013 2.99%
2012 11.54%
2011 -61.50%
2010 -9.12%
2009 147.46%
2008 -61.79%
2007 -75.15%
2006 19.82%
2005 -7.65%
2004 -69.11%
2003 253.51%
2002 -86.70%
2001 -26.92%
2000 -63.97%
1999 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$515.58 32.24%
US
$992.01 50.00%
NL
$111.24 -36.86%
AU
$736.64 6.99%
CH
$1.05K -7.55%
KR